The Food and Drug Administration has provided its first batch of ‘confidential’ documents, in accordance with a FOIA lawsuit by the Public Health and Medical Professionals for Transparency. The redacted documents were the basis of the FDA’s Emergency Use Authorization of the so called Pfizer-BioNTech “Vaccine” and subsequent federal vaccine mandates. : “Since the Pfizer-BioNTech’s product BNT162b2 does not stop the spread of SARS-CoV-2 and marginally lowers transmission, it is more accurately called a prophylactic therapeutic, and not a ‘vaccine.'” As reported earlier, the FDA does not intend to fully release the clinical trials information used to justify its authorization…
Comments